Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Lindley A. Barbee, Teresa A. Batteiger et al.|The Lancet|2025Cited by 26
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, C C Au, Chido Dziva Chikwari et al.|BMC Global and Public Health|2024Cited by 12